AAF is the only formula type recommended for all degrees of CMA severity (i.e. mild, moderate and severe). These formulas are based on amino acids, the building blocks of protein, which are considered virtually incapable of provoking an allergic reaction,3 while providing optimal nutrition for of the infant. Immediate usage of AAF is also recommended in infants with suspected CMA showing failure to thrive insufficient weight and/or length gain in order to rapidly stabilise the infants physical development.
In cases of mild to moderate, but not severe, CMA, the Taskforce advises that an eHF may be sufficient. When milk proteins are broken down (hydrolysed) into smaller fragments as happens in the production of eHFs their ability to provoke an allergic reaction is reduced. However, if symptoms do not improve sufficiently on an eHF, an AAF should be considered.
The SHS / Nutricia portfolio of hypoallergenic infant formulas is the only range of products that fully covers all degrees of CMA severity (i.e. mild to moderate and severe). The portfolio also includes the only AAF that is globally available and the most extensively clinically validated.
Jonathan Wogel, Global Allergy Director of SHS International says, SHS International and Nutricia have a long-standing heritage in the development the medical nutrition field, with over two decades experience in the production of specialised CMA formulas. To date however, there has been confusion over the diagnosis and usage of cows milk alternatives. We are proud to have been able to support the Act Against Allergy Taskforce in this initiative in order
|Contact: Claire Greeff|
Cohn & Wolfe, London